Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1317

1.

Impact of chromoscopy on adenoma detection in patients with Lynch syndrome: a prospective, multicenter, blinded, tandem colonoscopy study.

Rahmi G, Lecomte T, Malka D, Maniere T, Le Rhun M, Guimbaud R, Lapalus MG, Le Sidaner A, Moussata D, Caron O, Barbieux JP, Gaudric M, Coron E, Barange K, Ponchon T, Sautereau D, Samaha E, Saurin JC, Chaussade S, Laurent-Puig P, Chatellier G, Cellier C.

Am J Gastroenterol. 2015 Feb;110(2):288-98. doi: 10.1038/ajg.2014.423. Epub 2015 Jan 20.

PMID:
25601014
2.

Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening.

Smith RA, Manassaram-Baptiste D, Brooks D, Doroshenk M, Fedewa S, Saslow D, Brawley OW, Wender R.

CA Cancer J Clin. 2015 Jan-Feb;65(1):30-54. doi: 10.3322/caac.21261. Epub 2015 Jan 8. Review.

PMID:
25581023
3.

Participation in four rounds of a French colorectal cancer screening programme with guaiac faecal occult blood test: a population-based open cohort study.

Denis B, Gendre I, Perrin P.

J Med Screen. 2015 Jan 9. pii: 0969141314567795. [Epub ahead of print]

PMID:
25576338
4.

[An analysis of results of the elderly colorectal cancer screening study].

Zhang C, Fang Y, Hong Z, Jiang Q, Li W, Li J.

Zhonghua Nei Ke Za Zhi. 2014 Sep;53(9):715-8. Chinese.

PMID:
25511405
5.

Assessing generalizability of the findings of sigmoidoscopy screening trials: the case of SCORE trial.

Senore C, Bonelli L, Sciallero S, Casella C, Santarelli A, Armaroli P, Zanetti R, Segnan N.

J Natl Cancer Inst. 2014 Dec 9;107(1):385. doi: 10.1093/jnci/dju385. Print 2015 Jan.

PMID:
25492939
6.

Increasing colon cancer screening in primary care among African Americans.

Myers RE, Sifri R, Daskalakis C, DiCarlo M, Geethakumari PR, Cocroft J, Minnick C, Brisbon N, Vernon SW.

J Natl Cancer Inst. 2014 Dec 6;106(12). pii: dju344. doi: 10.1093/jnci/dju344. Print 2014 Dec.

PMID:
25481829
7.

Serum sCD26 for colorectal cancer screening in family-risk individuals: comparison with faecal immunochemical test.

Otero-Estévez O, De Chiara L, Rodríguez-Berrocal FJ, Páez de la Cadena M, Cubiella J, Castro I, Gonzalez-Mao C, Hernandez V, Martínez-Zorzano VS.

Br J Cancer. 2015 Jan 20;112(2):375-81. doi: 10.1038/bjc.2014.605. Epub 2014 Dec 2.

PMID:
25461801
8.
9.

Repeated screening with fecal immunochemical tests reduced the incidence of colorectal cancers in Saga, Japan.

Sakata N, Sakata Y, Shimoda R, Sakata H, Iwakiri R, Fujimoto K, Mizuguchi M, Irie H, Shimoda Y, Noshiro H.

Hepatogastroenterology. 2014 Jul-Aug;61(133):1224-8.

PMID:
25436287
10.

Follow up by CT-colonoscopy of patients with colostoma after resection on the occasion of colorectal cancer.

Nedevska M, Radionov M.

Khirurgiia (Sofiia). 2014;(2):56-62. Bulgarian, English.

PMID:
25417269
11.

Epidemiology of goblet cell and microvesicular hyperplastic polyps.

Qazi TM, O'Brien MJ, Farraye FA, Gould RW, Chen CA, Schroy PC 3rd.

Am J Gastroenterol. 2014 Dec;109(12):1922-32. doi: 10.1038/ajg.2014.325. Epub 2014 Oct 28.

PMID:
25350766
12.

Optimising the expansion of the National Bowel Cancer Screening Program.

Cenin DR, St John DJ, Ledger MJ, Slevin T, Lansdorp-Vogelaar I.

Med J Aust. 2014 Oct 20;201(8):456-61.

PMID:
25332032
13.

Flexible sigmoidoscopy screening for colorectal cancer.

Burki TK.

Lancet Oncol. 2014 Sep;15(10):e425. No abstract available.

PMID:
25328954
14.

Eliminating cost-sharing requirements for colon cancer screening in Medicare.

Howard DH, Guy GP Jr, Ekwueme DU.

Cancer. 2014 Dec 15;120(24):3850-2. doi: 10.1002/cncr.29093. Epub 2014 Oct 9.

PMID:
25302786
15.

Proximal shift of colorectal cancer. A persistent phenomenon with multiple causes, patterns and clinical implications.

Papagiorgis PC, Oikonomakis I, Delaportas D, Myoteri D, Arkoumani E, Thalassinos N, Zizi-Sermpetzoglou A.

J BUON. 2014 Jul-Sep;19(3):605-17. Review.

PMID:
25261642
16.

Committee opinion no 609: colorectal cancer screening strategies.

[No authors listed]

Obstet Gynecol. 2014 Oct;124(4):849-55. doi: 10.1097/01.AOG.0000454930.69435.fc. Review.

PMID:
25244458
17.

Optimising faecal occult blood screening:retrospective analysis of NHS Bowel Cancer Screening data to improve the screening algorithm.

Geraghty J, Butler P, Seaman H, Snowball J, Sarkar S, Blanks R, Halloran S, Bodger K, Rees CJ.

Br J Cancer. 2014 Nov 25;111(11):2156-62. doi: 10.1038/bjc.2014.480. Epub 2014 Sep 16.

PMID:
25225905
18.

Multiple colon polyposis.

Buturovic S.

Med Arh. 2014;68(3):221-2.

PMID:
25195359
19.

Guaiac faecal occult blood test performance at initial and repeat screens in the English Bowel Cancer Screening Programme.

Kearns B, Whyte S, Chilcott J, Patnick J.

Br J Cancer. 2014 Oct 28;111(9):1734-41. doi: 10.1038/bjc.2014.469. Epub 2014 Sep 2.

PMID:
25180767
20.

Impact of state-specific Medicaid reimbursement and eligibility policies on receipt of cancer screening.

Halpern MT, Romaire MA, Haber SG, Tangka FK, Sabatino SA, Howard DH.

Cancer. 2014 Oct 1;120(19):3016-24. doi: 10.1002/cncr.28704. Epub 2014 Aug 25.

PMID:
25154930
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk